References
Ahmed, M. A., Kartha, R. V., Brundage, R. C., Cloyd, J., Basu, C.,
Carlin, B. P., . . . Raymond, G. V. (2016). A model-based approach to
assess the exposure-response relationship of Lorenzo’s oil in
adrenoleukodystrophy. Br J Clin Pharmacol, 81 (6), 1058-1066.
doi:10.1111/bcp.12897
Aubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G.,
Naud-Saudreau, C., . . . et al. (1990). Reversal of early neurologic and
neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone
marrow transplantation. N Engl J Med, 322 (26), 1860-1866.
doi:10.1056/nejm199006283222607
Awaya, T., Kato, T., Niwa, A., Hiramatsu, H., Umeda, K., Watanabe, K., .
. . Adachi, S. (2011). Successful cord blood transplantation using a
reduced-intensity conditioning regimen for advanced childhood-onset
cerebral adrenoleukodystrophy. Pediatr Transplant, 15 (6),
E116-120. doi:10.1111/j.1399-3046.2009.01188.x
Baarine, M., Beeson, C., Singh, A., & Singh, I. (2015). ABCD1
deletion-induced mitochondrial dysfunction is corrected by SAHA:
implication for adrenoleukodystrophy. J Neurochem, 133 (3),
380-396. doi:10.1111/jnc.12992
Baarine, M., Khan, M., Singh, A., & Singh, I. (2015). Functional
Characterization of IPSC-Derived Brain Cells as a Model for X-Linked
Adrenoleukodystrophy. PLoS One, 10 (11), e0143238.
doi:10.1371/journal.pone.0143238
Banks, W. A. (2016). From blood-brain barrier to blood-brain interface:
new opportunities for CNS drug delivery. Nat Rev Drug Discov,
15 (4), 275-292. doi:10.1038/nrd.2015.21
Barendsen, R. W., Dijkstra, I. M. E., Visser, W. F., Alders, M., Bliek,
J., Boelen, A., . . . Kemp, S. (2020). Adrenoleukodystrophy Newborn
Screening in the Netherlands (SCAN Study): The X-Factor. Front
Cell Dev Biol, 8 , 499. doi:10.3389/fcell.2020.00499
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014). Pathophysiology
of X-linked adrenoleukodystrophy. Biochimie, 98 (100), 135-142.
doi:10.1016/j.biochi.2013.11.023
Bergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M.,
Valizada, E., . . . Stadelmann, C. (2019). Microglia damage precedes
major myelin breakdown in X-linked adrenoleukodystrophy and
metachromatic leukodystrophy. Glia, 67 (6), 1196-1209.
doi:10.1002/glia.23598
Bladowska, J., Kulej, D., Biel, A., Zimny, A., Kałwak, K., Owoc-Lempach,
J., . . . Sąsiadek, M. J. (2015). The Role of MR Imaging in the
Assessment of Clinical Outcomes in Children with X-Linked
Adrenoleukodystrophy after Allogeneic Haematopoietic Stem Cell
Transplantation. Pol J Radiol, 80 , 181-190.
doi:10.12659/pjr.893285
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Bougnères, P.,
Schmidt, M., Kalle, C. V., . . . Aubourg, P. (2012). Lentiviral
hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.Methods Enzymol, 507 , 187-198.
doi:10.1016/b978-0-12-386509-0.00010-7
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G.,
Schmidt, M., Kutschera, I., . . . Aubourg, P. (2009). Hematopoietic stem
cell gene therapy with a lentiviral vector in X-linked
adrenoleukodystrophy. Science, 326 (5954), 818-823.
doi:10.1126/science.1171242
Casasnovas, C., Ruiz, M., Schlüter, A., Naudí, A., Fourcade, S.,
Veciana, M., . . . Pujol, A. (2019). Biomarker Identification, Safety,
and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a
Phase II Pilot Study. Neurotherapeutics, 16 (4), 1167-1182.
doi:10.1007/s13311-019-00735-2
Castellano, A., Papinutto, N., Cadioli, M., Brugnara, G., Iadanza, A.,
Scigliuolo, G., . . . Salsano, E. (2016). Quantitative MRI of the spinal
cord and brain in adrenomyeloneuropathy: in vivo assessment of
structural changes. Brain, 139 (Pt 6), 1735-1746.
doi:10.1093/brain/aww068
Chen, Y., Zhang, X. H., Xu, L. P., Liu, K. Y., Qin, J., Yang, Y. L., &
Huang, X. J. (2019). [Haploidentical allogenetic hematopoietic stem
cell transplantation for X-linked adrenoleukodystrophy]. Beijing
Da Xue Xue Bao Yi Xue Ban, 51 (3), 409-413.
doi:10.19723/j.issn.1671-167X.2019.03.006
Ciftciler, R., Goker, H., Buyukasık, Y., Topcu, M., Gevher, N., &
Demiroglu, H. (2020). The experience of allogeneic hematopoietic stem
cell transplantation in a patient with X-linked adrenoleukodystrophy.Transfus Apher Sci, 59 (1), 102583.
doi:10.1016/j.transci.2019.06.019
Coppa, A., Guha, S., Fourcade, S., Parameswaran, J., Ruiz, M., Moser, A.
B., . . . Pujol, A. (2020). The peroxisomal fatty acid transporter
ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal
maintenance: A worm model for adrenoleukodystrophy. Free Radic
Biol Med, 152 , 797-809. doi:10.1016/j.freeradbiomed.2020.01.177
Curiel, J., Steinberg, S. J., Bright, S., Snowden, A., Moser, A. B.,
Eichler, F., . . . Vanderver, A. (2017). X-linked adrenoleukodystrophy
in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated
humans. Mol Genet Metab, 122 (3), 130-133.
doi:10.1016/j.ymgme.2017.08.012
de Beer, M., Engelen, M., & van Geel, B. M. (2014). Frequent occurrence
of cerebral demyelination in adrenomyeloneuropathy. Neurology,
83 (24), 2227-2231. doi:10.1212/wnl.0000000000001074
Deon, M., Garcia, M. P., Sitta, A., Barschak, A. G., Coelho, D. M.,
Schimit, G. O., . . . Vargas, C. R. (2008). Hexacosanoic and docosanoic
acids plasma levels in patients with cerebral childhood and asymptomatic
X-linked adrenoleukodystrophy: Lorenzo’s oil effect. Metab Brain
Dis, 23 (1), 43-49. doi:10.1007/s11011-007-9079-9
Deon, M., Marchetti, D. P., Donida, B., Wajner, M., & Vargas, C.
(2016). Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy.Cell Mol Neurobiol, 36 (4), 497-512. doi:10.1007/s10571-015-0234-2
Di Rocco, M., Doria-Lamba, L., & Caruso, U. (2001). Monozygotic twins
with X-linked adrenoleukodystrophy and different phenotypes. Ann
Neurol, 50 (3), 424. doi:10.1002/ana.1220
Doria, M., Nury, T., Delmas, D., Moreau, T., Lizard, G., & Vejux, A.
(2019). Protective function of autophagy during VLCFA-induced
cytotoxicity in a neurodegenerative cell model. Free Radic Biol
Med, 137 , 46-58. doi:10.1016/j.freeradbiomed.2019.04.016
Eichler, F., Duncan, C., Musolino, P. L., Orchard, P. J., De Oliveira,
S., Thrasher, A. J., . . . Williams, D. A. (2017). Hematopoietic
Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy. N Engl J
Med, 377 (17), 1630-1638. doi:10.1056/NEJMoa1700554
Eichler, F. S., Ren, J. Q., Cossoy, M., Rietsch, A. M., Nagpal, S.,
Moser, A. B., . . . Ransohoff, R. M. (2008). Is microglial apoptosis an
early pathogenic change in cerebral X-linked adrenoleukodystrophy?Ann Neurol, 63 (6), 729-742. doi:10.1002/ana.21391
Engelen, M., Kemp, S., & Poll-The, B. T. (2014). X-linked
adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol
Neurosci Rep, 14 (10), 486. doi:10.1007/s11910-014-0486-0
Fernandes, J. F., Bonfim, C., Kerbauy, F. R., Rodrigues, M., Esteves,
I., Silva, N. H., . . . Hamerschlak, N. (2018). Haploidentical bone
marrow transplantation with post transplant cyclophosphamide for
patients with X-linked adrenoleukodystrophy: a suitable choice in an
urgent situation. Bone Marrow Transplant, 53 (4), 392-399.
doi:10.1038/s41409-017-0015-2
Forss-Petter, S., Werner, H., Berger, J., Lassmann, H., Molzer, B.,
Schwab, M. H., . . . Nave, K. A. (1997). Targeted inactivation of the
X-linked adrenoleukodystrophy gene in mice. J Neurosci Res,
50 (5), 829-843.
doi:10.1002/(sici)1097-4547(19971201)50:5<829::Aid-jnr19>3.0.Co;2-w
Fourcade, S., Ferrer, I., & Pujol, A. (2015). Oxidative stress,
mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A
paradigm for axonal degeneration. Free Radic Biol Med, 88 (Pt A),
18-29. doi:10.1016/j.freeradbiomed.2015.05.041
Fourcade, S., Goicoechea, L., Parameswaran, J., Schlüter, A., Launay,
N., Ruiz, M., . . . Pujol, A. (2020). High-dose biotin restores redox
balance, energy and lipid homeostasis, and axonal health in a model of
adrenoleukodystrophy. Brain Pathol, 30 (5), 945-963.
doi:10.1111/bpa.12869
Görtz, A. L., Peferoen, L. A. N., Gerritsen, W. H., van Noort, J. M.,
Bugiani, M., & Amor, S. (2018). Heat shock protein expression in
cerebral X-linked adrenoleukodystrophy reveals astrocyte stress prior to
myelin loss. Neuropathol Appl Neurobiol, 44 (4), 363-376.
doi:10.1111/nan.12399
Galea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R.,
Aubourg, P., . . . Pujol, A. (2012). Oxidative stress underlying axonal
degeneration in adrenoleukodystrophy: a paradigm for multifactorial
neurodegenerative diseases? Biochim Biophys Acta, 1822 (9),
1475-1488. doi:10.1016/j.bbadis.2012.02.005
Gong, Y., Berenson, A., Laheji, F., Gao, G., Wang, D., Ng, C., . . .
Eichler, F. (2019). Intrathecal Adeno-Associated Viral Vector-Mediated
Gene Delivery for Adrenomyeloneuropathy. Hum Gene Ther, 30 (5),
544-555. doi:10.1089/hum.2018.079
Gong, Y., Mu, D., Prabhakar, S., Moser, A., Musolino, P., Ren, J., . . .
Eichler, F. S. (2015). Adenoassociated virus serotype 9-mediated gene
therapy for x-linked adrenoleukodystrophy. Mol Ther, 23 (5),
824-834. doi:10.1038/mt.2015.6
Gordon, H. B., Valdez, L., & Letsou, A. (2018). Etiology and treatment
of adrenoleukodystrophy: new insights from Drosophila. Dis Model
Mech, 11 (6). doi:10.1242/dmm.031286
Hartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017). A
Thyroid Hormone-Based Strategy for Correcting the Biochemical
Abnormality in X-Linked Adrenoleukodystrophy. Endocrinology,
158 (5), 1328-1338. doi:10.1210/en.2016-1842
Hartley, M. D., Shokat, M. D., DeBell, M. J., Banerji, T., Kirkemo, L.
L., & Scanlan, T. S. (2020). Pharmacological Complementation Remedies
an Inborn Error of Lipid Metabolism. Cell Chem Biol, 27 (5),
551-559.e554. doi:10.1016/j.chembiol.2020.02.008
Huffnagel, I. C., Laheji, F. K., Aziz-Bose, R., Tritos, N. A., Marino,
R., Linthorst, G. E., . . . Eichler, F. (2019). The Natural History of
Adrenal Insufficiency in X-Linked Adrenoleukodystrophy: An International
Collaboration. J Clin Endocrinol Metab, 104 (1), 118-126.
doi:10.1210/jc.2018-01307
Huffnagel, I. C., van Ballegoij, W. J. C., van Geel, B. M., Vos, J.,
Kemp, S., & Engelen, M. (2019). Progression of myelopathy in males with
adrenoleukodystrophy: towards clinical trial readiness. Brain,
142 (2), 334-343. doi:10.1093/brain/awy299
Jia, M. R., Wu, W. Z., Li, C. M., Cai, X. H., Zhang, L., Yan, F., . . .
Gu, M. H. (2019). Clinical characteristics and phenotype distribution in
10 Chinese patients with X-linked adrenoleukodystrophy. Exp Ther
Med, 18 (3), 1945-1952. doi:10.3892/etm.2019.7804
Jiang, H., Jiang, M. Y., Liu, S., Cai, Y. N., Liang, C. L., & Liu, L.
(2015). Combination of a Haploidentical Stem Cell Transplant With
Umbilical Cord Blood for Cerebral X-Linked Adrenoleukodystrophy.Pediatr Neurol, 53 (2), 163-165.e161.
doi:10.1016/j.pediatrneurol.2015.05.002
Köhler, W., Curiel, J., & Vanderver, A. (2018). Adulthood
leukodystrophies. Nat Rev Neurol, 14 (2), 94-105.
doi:10.1038/nrneurol.2017.175
Kühl, J. S., Suarez, F., Gillett, G. T., Hemmati, P. G., Snowden, J. A.,
Stadler, M., . . . Arnold, R. (2017). Long-term outcomes of allogeneic
haematopoietic stem cell transplantation for adult cerebral X-linked
adrenoleukodystrophy. Brain, 140 (4), 953-966.
doi:10.1093/brain/awx016
Kühl, J. S., Kupper, J., Baqué, H., Ebell, W., Gärtner, J., Korenke, C.,
. . . Steinfeld, R. (2018). Potential Risks to Stable Long-term Outcome
of Allogeneic Hematopoietic Stem Cell Transplantation for Children With
Cerebral X-linked Adrenoleukodystrophy. JAMA Netw Open, 1 (3),
e180769. doi:10.1001/jamanetworkopen.2018.0769
Kawaguchi, K., & Morita, M. (2016). ABC Transporter Subfamily D:
Distinct Differences in Behavior between ABCD1-3 and ABCD4 in
Subcellular Localization, Function, and Human Disease. Biomed Res
Int, 2016 , 6786245. doi:10.1155/2016/6786245
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., &
Engelen, M. (2016). Adrenoleukodystrophy - neuroendocrine pathogenesis
and redefinition of natural history. Nat Rev Endocrinol, 12 (10),
606-615. doi:10.1038/nrendo.2016.90
Kobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997).
Adrenoleukodystrophy protein-deficient mice represent abnormality of
very long chain fatty acid metabolism. Biochem Biophys Res Commun,
232 (3), 631-636. doi:10.1006/bbrc.1997.6340
Korenke, G. C., Fuchs, S., Krasemann, E., Doerr, H. G., Wilichowski, E.,
Hunneman, D. H., & Hanefeld, F. (1996). Cerebral adrenoleukodystrophy
(ALD) in only one of monozygotic twins with an identical ALD genotype.Ann Neurol, 40 (2), 254-257. doi:10.1002/ana.410400221
López-Erauskin, J., Galino, J., Bianchi, P., Fourcade, S., Andreu, A.
L., Ferrer, I., . . . Pujol, A. (2012). Oxidative stress modulates
mitochondrial failure and cyclophilin D function in X-linked
adrenoleukodystrophy. Brain, 135 (Pt 12), 3584-3598.
doi:10.1093/brain/aws292
López-Erauskin, J., Fourcade, S., Galino, J., Ruiz, M., Schlüter, A.,
Naudi, A., . . . Pujol, A. (2011). Antioxidants halt axonal degeneration
in a mouse model of X-adrenoleukodystrophy. Ann Neurol, 70 (1),
84-92. doi:10.1002/ana.22363
Launay, N., Aguado, C., Fourcade, S., Ruiz, M., Grau, L., Riera, J., . .
. Pujol, A. (2015). Autophagy induction halts axonal degeneration in a
mouse model of X-adrenoleukodystrophy. Acta Neuropathol, 129 (3),
399-415. doi:10.1007/s00401-014-1378-8
Launay, N., Ruiz, M., Grau, L., Ortega, F. J., Ilieva, E. V., Martínez,
J. J., . . . Fourcade, S. (2017). Tauroursodeoxycholic bile acid arrests
axonal degeneration by inhibiting the unfolded protein response in
X-linked adrenoleukodystrophy. Acta Neuropathol, 133 (2), 283-301.
doi:10.1007/s00401-016-1655-9
Lee, H., Ko, J. M., & Lee, S. H. (2020). Generalized skin
hyperpigmentation as the only manifestation of X-linked
adrenoleucodystrophy. Br J Dermatol, 182 (1), 239-240.
doi:10.1111/bjd.18310
Lee, S., Clinard, K., Young, S. P., Rehder, C. W., Fan, Z., Calikoglu,
A. S., . . . Taylor, J. L. (2020). Evaluation of X-Linked
Adrenoleukodystrophy Newborn Screening in North Carolina. JAMA
Netw Open, 3 (1), e1920356. doi:10.1001/jamanetworkopen.2019.20356
Liberato, A. P., Mallack, E. J., Aziz-Bose, R., Hayden, D., Lauer, A.,
Caruso, P. A., . . . Eichler, F. S. (2019). MRI brain lesions in
asymptomatic boys with X-linked adrenoleukodystrophy. Neurology,
92 (15), e1698-e1708. doi:10.1212/wnl.0000000000007294
Lu, J. F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B.,
Moser, H. W., & Smith, K. D. (1997). A mouse model for X-linked
adrenoleukodystrophy. Proc Natl Acad Sci U S A, 94 (17),
9366-9371. doi:10.1073/pnas.94.17.9366
Luis, A. (2020). The Old and the New: Prospects for Non-Integrating
Lentiviral Vector Technology. Viruses, 12 (10).
doi:10.3390/v12101103
Maier, E. M., Mayerhofer, P. U., Asheuer, M., Köhler, W., Rothe, M.,
Muntau, A. C., . . . Berger, J. (2008). X-linked adrenoleukodystrophy
phenotype is independent of ABCD2 genotype. Biochem Biophys Res
Commun, 377 (1), 176-180. doi:10.1016/j.bbrc.2008.09.092
Majori, M., Scarascia, A., Anghinolfi, M., Pisi, R., Gnetti, L., &
Casalini, A. G. (2014). Lipoid pneumonia as a complication of Lorenzo’s
oil therapy in a patient with adrenoleukodystrophy. J Bronchology
Interv Pulmonol, 21 (3), 271-273. doi:10.1097/lbr.0000000000000084
Marchetti, D. P., Donida, B., da Rosa, H. T., Manini, P. R., Moura, D.
J., Saffi, J., . . . Vargas, C. R. (2015). Protective effect of
antioxidants on DNA damage in leukocytes from X-linked
adrenoleukodystrophy patients. Int J Dev Neurosci, 43 , 8-15.
doi:10.1016/j.ijdevneu.2015.03.004
Marcucci, K. T., Jadlowsky, J. K., Hwang, W. T., Suhoski-Davis, M.,
Gonzalez, V. E., Kulikovskaya, I., . . . June, C. H. (2018). Retroviral
and Lentiviral Safety Analysis of Gene-Modified T Cell Products and
Infused HIV and Oncology Patients. Mol Ther, 26 (1), 269-279.
doi:10.1016/j.ymthe.2017.10.012
Morató, L., Galino, J., Ruiz, M., Calingasan, N. Y., Starkov, A. A.,
Dumont, M., . . . Pujol, A. (2013). Pioglitazone halts axonal
degeneration in a mouse model of X-linked adrenoleukodystrophy.Brain, 136 (Pt 8), 2432-2443. doi:10.1093/brain/awt143
Morita, M., & Imanaka, T. (2012). Peroxisomal ABC transporters:
structure, function and role in disease. Biochim Biophys Acta,
1822 (9), 1387-1396. doi:10.1016/j.bbadis.2012.02.009
Morita, M., Shinbo, S., Asahi, A., & Imanaka, T. (2012). Very long
chain fatty acid β-oxidation in astrocytes: contribution of the
ABCD1-dependent and -independent pathways. Biol Pharm Bull,
35 (11), 1972-1979. doi:10.1248/bpb.b12-00411
Moser, H. W., Moser, A. B., Hollandsworth, K., Brereton, N. H., &
Raymond, G. V. (2007). ”Lorenzo’s oil” therapy for X-linked
adrenoleukodystrophy: rationale and current assessment of efficacy.J Mol Neurosci, 33 (1), 105-113. doi:10.1007/s12031-007-0041-4
Moser, H. W., Moser, A. E., Singh, I., & O’Neill, B. P. (1984).
Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and
therapy. Ann Neurol, 16 (6), 628-641. doi:10.1002/ana.410160603
Muneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J.,
& Forss-Petter, S. (2014). Abcd2 is a strong modifier of the metabolic
impairments in peritoneal macrophages of ABCD1-deficient mice.PLoS One, 9 (9), e108655. doi:10.1371/journal.pone.0108655
Musolino, P. L., Gong, Y., Snyder, J. M., Jimenez, S., Lok, J., Lo, E.
H., . . . Eichler, F. S. (2015). Brain endothelial dysfunction in
cerebral adrenoleukodystrophy. Brain, 138 (Pt 11), 3206-3220.
doi:10.1093/brain/awv250
Niizuma, H., Uematsu, M., Sakamoto, O., Uchiyama, T., Horino, S., Onuma,
M., . . . Tsuchiya, S. (2012). Successful cord blood transplantation
with reduced-intensity conditioning for childhood cerebral X-linked
adrenoleukodystrophy at advanced and early stages. Pediatr
Transplant, 16 (2), E63-70. doi:10.1111/j.1399-3046.2011.01539.x
Nixon, R. A. (2013). The role of autophagy in neurodegenerative disease.Nat Med, 19 (8), 983-997. doi:10.1038/nm.3232
Nowak, J., Löbel, U., Wölfl, M., Schlegel, P. G., & Warmuth-Metz, M.
(2015). MRI demyelination pattern and clinical course in a child with
cerebral X-linked adrenoleukodystrophy (X-ALD). Acta Radiol Open,
4 (4), 2047981615573655. doi:10.1177/2047981615573655
Orr, M. E., & Oddo, S. (2013). Autophagic/lysosomal dysfunction in
Alzheimer’s disease. Alzheimers Res Ther, 5 (5), 53.
doi:10.1186/alzrt217
Ozdemir Kutbay, N., Ozbek, M. N., Sarer Yurekli, B., & Demirbilek, H.
(2019). A Distinct Clinical Phenotype in Two Siblings with X-linked
Adrenoleukodystrophy. Neuro Endocrinol Lett, 40 (1), 36-40.
Paik, M. J., Kim, K. R., Yoon, H. R., & Kim, H. J. (2001). Diagnostic
patterns of very-long-chain fatty acids in plasma of patients with
X-linked adrenoleukodystrophy. J Chromatogr B Biomed Sci Appl,
760 (1), 149-157. doi:10.1016/s0378-4347(01)00263-8
Petrillo, S., Piemonte, F., Pastore, A., Tozzi, G., Aiello, C., Pujol,
A., . . . Bertini, E. (2013). Glutathione imbalance in patients with
X-linked adrenoleukodystrophy. Mol Genet Metab, 109 (4), 366-370.
doi:10.1016/j.ymgme.2013.05.009
Pierpont, E. I., Eisengart, J. B., Shanley, R., Nascene, D., Raymond, G.
V., Shapiro, E. G., . . . Miller, W. P. (2017). Neurocognitive
Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at
an Early Stage of Childhood Cerebral Adrenoleukodystrophy. JAMA
Neurol, 74 (6), 710-717. doi:10.1001/jamaneurol.2017.0013
Pujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot,
N., . . . Mandel, J. L. (2004). Functional overlap between ABCD1 (ALD)
and ABCD2 (ALDR) transporters: a therapeutic target for
X-adrenoleukodystrophy. Hum Mol Genet, 13 (23), 2997-3006.
doi:10.1093/hmg/ddh323
Pujol, A., Hindelang, C., Callizot, N., Bartsch, U., Schachner, M., &
Mandel, J. L. (2002). Late onset neurological phenotype of the X-ALD
gene inactivation in mice: a mouse model for adrenomyeloneuropathy.Hum Mol Genet, 11 (5), 499-505. doi:10.1093/hmg/11.5.499
Raas, Q., Gondcaille, C., Hamon, Y., Leoni, V., Caccia, C., Ménétrier,
F., . . . Savary, S. (2019). CRISPR/Cas9-mediated knockout of Abcd1 and
Abcd2 genes in BV-2 cells: novel microglial models for X-linked
Adrenoleukodystrophy. Biochim Biophys Acta Mol Cell Biol Lipids,
1864 (5), 704-714. doi:10.1016/j.bbalip.2019.02.006
Ranea-Robles, P., Launay, N., Ruiz, M., Calingasan, N. Y., Dumont, M.,
Naudí, A., . . . Pujol, A. (2018). Aberrant regulation of the
GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.EMBO Mol Med, 10 (8). doi:10.15252/emmm.201708604
Raymond, G. V., Aubourg, P., Paker, A., Escolar, M., Fischer, A.,
Blanche, S., . . . Lund, T. (2019). Survival and Functional Outcomes in
Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic
Stem Cell Transplantation. Biol Blood Marrow Transplant, 25 (3),
538-548. doi:10.1016/j.bbmt.2018.09.036
Rockenbach, F. J., Deon, M., Marchese, D. P., Manfredini, V., Mescka,
C., Ribas, G. S., . . . Vargas, C. R. (2012). The effect of bone marrow
transplantation on oxidative stress in X-linked adrenoleukodystrophy.Mol Genet Metab, 106 (2), 231-236. doi:10.1016/j.ymgme.2012.03.019
Santosh Rai, P. V., Suresh, B. V., Bhat, I. G., Sekhar, M., &
Chakraborti, S. (2013). Childhood adrenoleukodystrophy - Classic and
variant - Review of clinical manifestations and magnetic resonance
imaging. J Pediatr Neurosci, 8 (3), 192-197.
doi:10.4103/1817-1745.123661
Sarkar, S. (2013). Regulation of autophagy by mTOR-dependent and
mTOR-independent pathways: autophagy dysfunction in neurodegenerative
diseases and therapeutic application of autophagy enhancers.Biochem Soc Trans, 41 (5), 1103-1130. doi:10.1042/bst20130134
Sassa, T., Wakashima, T., Ohno, Y., & Kihara, A. (2014). Lorenzo’s oil
inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated
very long-chain fatty acid. J Lipid Res, 55 (3), 524-530.
doi:10.1194/jlr.M044586
Sghaier, R., Zarrouk, A., Nury, T., Badreddine, I., O’Brien, N.,
Mackrill, J. J., . . . Lizard, G. (2019). Biotin attenuation of
oxidative stress, mitochondrial dysfunction, lipid metabolism alteration
and 7β-hydroxycholesterol-induced cell death in 158N murine
oligodendrocytes. Free Radic Res, 53 (5), 535-561.
doi:10.1080/10715762.2019.1612891
Singh, I., & Pujol, A. (2010). Pathomechanisms underlying
X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol,
20 (4), 838-844. doi:10.1111/j.1750-3639.2010.00392.x
Sivachenko, A., Gordon, H. B., Kimball, S. S., Gavin, E. J., Bonkowsky,
J. L., & Letsou, A. (2016). Neurodegeneration in a Drosophila model of
adrenoleukodystrophy: the roles of the Bubblegum and Double bubble
acyl-CoA synthetases. Dis Model Mech, 9 (4), 377-387.
doi:10.1242/dmm.022244
Son, D., Quan, Z., Kang, P. J., Park, G., Kang, H. C., & You, S.
(2017). Generation of two induced pluripotent stem cell (iPSC) lines
from X-linked adrenoleukodystrophy (X-ALD) patients with
adrenomyeloneuropathy (AMN). Stem Cell Res, 25 , 46-49.
doi:10.1016/j.scr.2017.10.003
Strachan, L. R., Stevenson, T. J., Freshner, B., Keefe, M. D., Miranda
Bowles, D., & Bonkowsky, J. L. (2017). A zebrafish model of X-linked
adrenoleukodystrophy recapitulates key disease features and demonstrates
a developmental requirement for abcd1 in oligodendrocyte patterning and
myelination. Hum Mol Genet, 26 (18), 3600-3614.
doi:10.1093/hmg/ddx249
Stradomska, T. J., Drabko, K., Moszczyńska, E., & Tylki-Szymańska, A.
(2014). Monitoring of very long-chain fatty acids levels in X-linked
adrenoleukodystrophy, treated with haematopoietic stem cell
transplantation and Lorenzo’s Oil. Folia Neuropathol, 52 (2),
159-163. doi:10.5114/fn.2014.43787
van de Beek, M. C., Dijkstra, I. M., van Lenthe, H., Ofman, R.,
Goldhaber-Pasillas, D., Schauer, N., . . . Kemp, S. (2016).
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in
Mice and Man. PLoS One, 11 (4), e0154597.
doi:10.1371/journal.pone.0154597
van de Beek, M. C., Ofman, R., Dijkstra, I., Wijburg, F., Engelen, M.,
Wanders, R., & Kemp, S. (2017). Lipid-induced endoplasmic reticulum
stress in X-linked adrenoleukodystrophy. Biochim Biophys Acta Mol
Basis Dis, 1863 (9), 2255-2265. doi:10.1016/j.bbadis.2017.06.003
van de Stadt, S. I. W., van Ballegoij, W. J. C., Labounek, R.,
Huffnagel, I. C., Kemp, S., Nestrasil, I., & Engelen, M. (2020). Spinal
cord atrophy as a measure of severity of myelopathy in
adrenoleukodystrophy. J Inherit Metab Dis, 43 (4), 852-860.
doi:10.1002/jimd.12226
van Geel, B. M., Poll-The, B. T., Verrips, A., Boelens, J. J., Kemp, S.,
& Engelen, M. (2015). Hematopoietic cell transplantation does not
prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective
study. J Inherit Metab Dis, 38 (2), 359-361.
doi:10.1007/s10545-014-9797-1
Vogel, B. H., Bradley, S. E., Adams, D. J., D’Aco, K., Erbe, R. W.,
Fong, C., . . . Caggana, M. (2015). Newborn screening for X-linked
adrenoleukodystrophy in New York State: diagnostic protocol,
surveillance protocol and treatment guidelines. Mol Genet Metab,
114 (4), 599-603. doi:10.1016/j.ymgme.2015.02.002
Warren, K. E. (2018). Beyond the Blood:Brain Barrier: The Importance of
Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS
Tumors, Including Diffuse Intrinsic Pontine Glioma. Front Oncol,
8 , 239. doi:10.3389/fonc.2018.00239
Weinhofer, I., Zierfuss, B., Hametner, S., Wagner, M., Popitsch, N.,
Machacek, C., . . . Berger, J. (2018). Impaired plasticity of
macrophages in X-linked adrenoleukodystrophy. Brain, 141 (8),
2329-2342. doi:10.1093/brain/awy127
Wiesinger, C., Eichler, F. S., & Berger, J. (2015). The genetic
landscape of X-linked adrenoleukodystrophy: inheritance, mutations,
modifier genes, and diagnosis. Appl Clin Genet, 8 , 109-121.
doi:10.2147/tacg.S49590
Wiesinger, C., Kunze, M., Regelsberger, G., Forss-Petter, S., & Berger,
J. (2013). Impaired very long-chain acyl-CoA β-oxidation in human
X-linked adrenoleukodystrophy fibroblasts is a direct consequence of
ABCD1 transporter dysfunction. J Biol Chem, 288 (26), 19269-19279.
doi:10.1074/jbc.M112.445445
Wu, C., Iwamoto, T., Igarashi, J., Miyajima, T., Hossain, M. A.,
Yanagisawa, H., . . . Eto, Y. (2017). Application of a diagnostic
methodology by quantification of 26:0 lysophosphatidylcholine in dried
blood spots for Japanese newborn screening of X-linked
adrenoleukodystrophy. Mol Genet Metab Rep, 12 , 115-118.
doi:10.1016/j.ymgmr.2017.06.004
Yeon, G. B., Son, D., Kang, P. J., Oh, S. M., Lim, H., Kang, H. C., . .
. Kim, D. S. (2019). Generation of an induced pluripotent stem cell
(iPSC) line from a 42-year-old adult cerebral type X-linked
adrenoleukodystrophy (X-ALD) patient. Stem Cell Res, 36 , 101425.
doi:10.1016/j.scr.2019.101425
Zierfuss, B., Weinhofer, I., Kühl, J. S., Köhler, W., Bley, A., Zauner,
K., . . . Berger, J. (2020). Vorinostat in the acute neuroinflammatory
form of X-linked adrenoleukodystrophy. Ann Clin Transl Neurol,
7 (5), 639-652. doi:10.1002/acn3.51015